Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Medtronic Boosts Divident While Planning Share Buyback

June 20 (Bloomberg) -- Medtronic Inc., the largest maker of heart rhythm and spinal devices, increased its stock buyback program by 80 million shares and boosted its quarterly cash dividend to 28 cents per share.

The increase brings Medtronic’s annual dividend to $1.12 per share for a current yield of 2.2 percent, the Minneapolis-based company said today in a statement. Medtronic has raised its dividend each year for the past 36 years. The share repurchase program accounts for about 8 percent of the company’s outstanding common stock.

Medtronic is committed to returning 50 percent of its free cash flow to investors each year through dividends and share repurchases, Omar Ishrak, chief executive officer of the Minneapolis-based company, said in the statement. The dividend is payable July 26 to shareholders of record at the close of business on July 5. Share repurchases will be made on the open market, the company said.

The policy “still gives us ample flexibility to make necessary investments for sustainable growth,” Ishrak said.

Medtronic said it has bought more than 142 million shares for $5.6 billion in the last five years.

To contact the reporter on this story: Michelle Fay Cortez in Minneapolis at mcortez@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.